Making the T1D Vaccine a Reality

Nanoparticle-based vaccine is designed to re-educate the immune system and halt the attack on the pancreas Over the last three years, Selecta Bioscience, a clinical stage biotechnology company, has been developing nanoparticles called Synthetic Vaccine Particle (SVP) as an immunotherapy for Type 1 diabetes (T1D) with support from JDRF and it was announced this week […]

JDRF-Funded Research Leads to Beta Cell Replacement Breakthrough

A new method for converting stem cells to beta cells could speed encapsulated cell replacement product development and research to cure type 1 diabetes Insulin therapy has long been the only method of treating type 1 diabetes (T1D), but a major breakthrough in producing replacement beta cells is bringing new hope that more effective, alternative […]

JDRF 2015 Children’s Congress application site remains open

JDRF is pleased to announce that applications for JDRF 2015 Children’s Congress are currently being accepted. JDRF Children’s Congress, our highest profile advocacy event, is held every two years in the nation’s capital. Next year’s event will take place from July 13 to 15, 2015. It will include more than 150 children, ages 4 to […]

A New Pathway to Beta Cells

Innovative process could increase beta cell supply for type 1 diabetes research and encapsulated cell replacement products An important new technique to more rapidly convert human embryonic stem cells (hESCs) into cells similar to pancreatic beta cells was reported recently in Nature Biotechnology. In a study partially funded by JDRF, Dr. Timothy Kieffer of the […]

CGM-Medicare Bill Introduced in House

JDRF Commends U.S. Representatives Reed, DeGette and Whitfield for Introducing Continuous Glucose Monitor (CGM) Coverage Legislation JDRF commends U.S. Representatives Tom Reed (R-NY), Diana DeGette (D-CO) and Ed Whitfield (R-KY) for introducing legislation, H.R. 5644, the ‘Medicare CGM Access Act of 2014,’ calling for continuous glucose monitor (CGM) coverage by Medicare. This legislation (which now […]

Unlocking Type 1 Diabetes Data

JDRF partners with Tidepool on data integration software for better type 1 diabetes management JDRF is partnering with the non-profit organization Tidepool to develop a new data integration tool for people with type 1 diabetes (T1D) who use insulin pumps, continuous glucose monitors, or blood glucose meters. The new tool at the center of the […]

Volunteer Spotlight: Martin Gilmore

Volunteer Spotlight: Martin Gilmore

Martin Gilmore and his wife Susan were Co-Chairs of the Piedmont Triad Hope Gala in 2013. Martin Gilmore is a focused professional and dedicated father who is “in the game” until JDRF has accomplished its vision of creating a world without type 1 diabetes (T1D). Why JDRF? Martin’s daughter, Margaret, was diagnosed with T1D in 2007 […]

A Gut Reaction to Type 1 Diabetes

JDRF consortium defines roadmap for testing potential links between gut microbes and type 1 diabetes One of the first questions a person or parent of a child diagnosed with type 1 diabetes (T1D) often asks is, “what caused this?” While we have learned a lot about T1D, we still do not have a simple answer […]

A New Switch Hitter for Type 1 Diabetes Discovered

Pancreatic cells are more adaptable and possess a greater potential for self-healing than previously assumed For decades, the prevailing wisdom was that beta cells could not regenerate and that their loss in type 1 diabetes (T1D) was irreversible—the reason why people with T1D require insulin injections for life. JDRF-funded research is helping rewrite the textbook […]